Evaluation of oral zinc therapy in Acne Vulgaris disease
Phase 3
- Conditions
- Acne Vulgaris.Acne vulgarisL70.0
- Registration Number
- IRCT20190505043485N1
- Lead Sponsor
- Boushehr University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
2nd and 3rd grade of Acne Vulgaris patients depends on Pillsburg classification
Exclusion Criteria
The patients with Gastrointestinal disorder
The pregnant patients and breast feeding mothers
Using other topical and oral anti Acne drugs
Patients with Grade 1 and 4 Acne Vulgaris
Female patients with hormonal disorders
Patients with oral Isotretinoin in the last 3 months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduce in number of Acne. Timepoint: Evaluation the number of Acne in 14 days. Method of measurement: Observational.
- Secondary Outcome Measures
Name Time Method